₹102.04
-0.08 (-0.08%)
As of 18 Sept 2026, Bal Pharma Ltd share price is ₹102.04. The stock opened at ₹102.04 and had closed at ₹102.12 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹59.69 and a high of ₹124.68. In terms of performance, Bal Pharma Ltd share price has increased by 51.07% over the past six months and has increased by 21.53% over the last year.
BALPHARMA Stock Price Chart
Bal Pharma Ltd Overview
Market cap₹163 Crs
Volume3,304
Prev. Close₹102.12
Year range₹59.69 - ₹124.68
ISININE083D01012
About BALPHARMA
Bal Pharma is engaged in the manufacturing and selling of pharmaceutical products.
Bal Pharma Ltd Historical Performance
1 Month Return19.17%
6 Month Return52.42%
3 Year Return6.46%
3 Month Return14.94%
1 Year Return14.83%
5 Year Return-0.76%
Bal Pharma Ltd Fundamentals
ROCE(TTM)8.80%
P/E Ratio (TTM)21.41
P/B Ratio1.56
Debt to Equity1.48
ROE6.49%
EPS (TTM)4.77
Dividend Yield1.18%
Book Value65.39
Profit Margin2.28%
Operating Margin6.80%
Bal Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 312.80 | 304.65 | 340.84 | 305.29 | 286.86 |
| EBITDA | 34.24 | 32.23 | 33.83 | 28.49 | 29.70 |
| Net Profit | 6.75 | 7.80 | 7.73 | 6.13 | 8.58 |
| EPS | 4.51 | 4.89 | 6.72 | 3.90 | 5.79 |
Bal Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 95.23 |
| Resistance 1 (R1) | 111.76 |
| Pivot Point | 104.86 |
Bal Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 17-Sep-2026 | 27-May-2026 | 17-Sep-2026 | Final | ₹1.20 |
| 18-Sep-2025 | 29-May-2025 | 18-Sep-2025 | Final | ₹1.20 |
| 17-Sep-2024 | 28-May-2024 | 19-Sep-2024 | Final | ₹1.20 |
| 18-Sep-2023 | 29-May-2023 | 19-Sep-2023 | Final | ₹1.00 |
| 13-Sep-2022 | 30-May-2022 | 15-Sep-2022 | Final | ₹1.00 |
BALPHARMA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Shailesh Siroya | Managing Director |
| Himesh Virupakshaya | E D & Wholetime Directorector |
| H S Venkatesh | Non Executive Independent Director |
Bal Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Bal Pharma Ltd today is ₹102.04 on NSE and ₹102.04 on BSE.
- The 52-week high of Bal Pharma Ltd is ₹124.68, while the 52-week low is ₹59.69.
- The current market capitalisation of Bal Pharma Ltd is approximately ₹163 crore.
- The P/E (Price-to-Earnings) ratio of Bal Pharma Ltd is 14.09. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Bal Pharma Ltd is 1.46. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Bal Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BALPHARMA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Bal Pharma Ltd has delivered a return of approximately 6.46%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Bal Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 50.86% promoters, 0.15% FIIs, 0.00% DIIs, and 32.86% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
